Evia HF-T 

Cardiac Resynchronization Therapy Pacemaker (CRT-P) for patients with Heart Failure

The Evia HF-T series is the first set of cardiac resynchronization therapy (CRT-P) devices approved for use in an MRI environment. In addition to the latest CRT-P therapy, the Evia HF-T series offers all the benefits of daily remote patient monitoring with our unique BIOTRONIK Home Monitoring^®, plus the detailed trend information available via our Heart Failure Monitor.

 

 

Access to MRI with ProMRI^® 

• World´s first MR Conditional CRT-P system 
• Wide choice of MR conditional leads for RA, RV and LV application with excellent; handling and optimal electrical performance

 Access to optimal therapy 

• Capture Control (RA, RV and LV) and 6 MultiSelect LV pacing polarities as part of a range of solutions for continuous, effective biventricular pacing without complications.
• Closed Loop Stimulation (CLS) to optimize individual rate regulation for patient with chronotropic incompetence (CI). CI is a common comorbidity present in 70% of the advanced HF patients¹. CLS is the most physiological rate adapting system and is the only sensor to react on both physical and mental stress. 

Remote access to the patient´s data record 

• Timely intervention using BIOTRONIK Home Monitoring. The results of the COMPAS study show a median gain of 122 days for medical intervention through early detection of clinically relevant events in pacemaker patients². 
• Clinical trend data with Heart Failure Monitor offer a daily updated view on the patients HF status and the effectiveness of the CRT therapy.

 

 

¹    Jorde UP et al.; European Journal of Heart Failure; 10 (2008) 96–101.
²    Mabo P et al.; The COMPAS Trial; European Heart Journal 2011; doi: 10.1093 / eurheartj / ehr419.